ESR2 and prostate carcinoma: Only 3 out of 10 selected SNPs (ESR1 Ex1+392T>C, ESR2 Ex8+229G>A, and ESR1 Ex4-122C>G) were studied in the past [28], [42], where null associations with prostate cancer risk were observed, consistent with our study findings.